Eu Ivdd Eu Ivd Annex 2 List B On The Market 🇨🇳 China

Prostate Specific Antigen (PSA) Diagnostic Kit

Devices (same UDI-DI)
1
Certificates
1
Countries
0
Notified Bodies
1

Basic Information

Primary DI
06971348760106
Basic UDI-DI Code
B-06971348760106
Reference
MF-46-20
Device Types
Single use
Regulation
Eu Ivdd
Classification
Eu Ivd Annex 2 List B
Status
On The Market

Additional Description

The PSA is applicable to the quantitative detection of the concentration of PSA in human serum or plasma. A number of studies have proved that serum and plasma PSA levels can predict prostate cancer. For patients with prostate cancer after surgery or treatment, abnormal PSA levels can predict recurrence or other residual diseases. PSA testing has been widely used as an aid to the management of prostate cancer patients.

CND Nomenclature Codes

Code Description
W0102030113 TOTAL PROSTATIC SPECIFIC ANTIGEN

Certificates

Type Number
IVDD Annex IV (excluding sections 4, 6) No. V1 109172 0002 Rev. 00

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd Annex 2 List B) and regulation (EU IVDD).

View all